Liu Dawei, Fu Binbin, Wang Yixin
Department of Cardiology, Tangshan Gongren Hospital Tangshan 063000, Hebei, China.
Department of Cardiology, The People's Hospital of Qianxi County Qianxi 064300, Hebei, China.
Am J Transl Res. 2025 Apr 15;17(4):3162-3170. doi: 10.62347/TRKY5505. eCollection 2025.
To investigate the effects of early stepwise controlled decompression combined with mild hypothermia therapy (MHT) on clinical outcomes in patients with severe hypertensive intracerebral hemorrhage (sHICH).
A total of 80 sHICH patients were included, with 32 cases in the control group receiving conventional craniotomy for hematoma evacuation and MHT, and 48 cases in the observation group undergoing early stepwise controlled decompression plus MHT. The two groups were compared in terms of treatment efficacy, hematoma clearance rate, prognosis, National Institutes of Health Stroke Scale (NIHSS) and Functional Ambulation Category (FAC) scores, complications, cerebral edema volume, and serum biochemical indices.
The observation group demonstrated significantly better efficacy, higher hematoma clearance rates, and improved clinical outcomes compared to the control group (all P<0.05). Postoperatively, the observation group had significantly lower NIHSS scores, reduced levels of neuron-specific enolase, central nervous system-specific protein, and malondialdehyde, as well as lower incidences of encephalocele, cerebral infarction, and delayed intracranial hematoma (all P<0.05). Additionally, cerebral edema volume was significantly reduced, while FAC scores were notably higher in the observation group (both P<0.05).
Early stepwise controlled decompression combined with MHT is highly effective in the treatment of sHICH, leading to better neurological recovery, reduced cerebral edema, and improved biochemical profiles.
探讨早期分步控制性减压联合亚低温治疗(MHT)对重症高血压脑出血(sHICH)患者临床结局的影响。
纳入80例sHICH患者,对照组32例接受传统开颅血肿清除术及MHT,观察组48例接受早期分步控制性减压联合MHT。比较两组的治疗效果、血肿清除率、预后、美国国立卫生研究院卒中量表(NIHSS)和功能步行分类(FAC)评分、并发症、脑水肿体积及血清生化指标。
与对照组相比,观察组疗效显著更好,血肿清除率更高,临床结局改善(均P<0.05)。术后,观察组NIHSS评分显著更低,神经元特异性烯醇化酶、中枢神经系统特异性蛋白和丙二醛水平降低,脑膨出、脑梗死和迟发性颅内血肿的发生率也更低(均P<0.05)。此外,观察组脑水肿体积显著减小,而FAC评分显著更高(均P<0.05)。
早期分步控制性减压联合MHT治疗sHICH疗效显著,可使神经功能恢复更好,减轻脑水肿,改善生化指标。